News
Learn when rashes signal medical emergencies. Color, location, and symptoms reveal dangerous conditions needing urgent care.
Certain antihistamines found in common allergy medications and sleep aids are liked to an increased dementia risk. Doctors ...
Did you know your child's smartphone has safety features that could save their life? While most parents know they should ...
I was skeptical that the 2025 Porsche 911 Carrera would live up to all the praise the 911 receives, but it really is just as ...
A new study warns that common anti-inflammatory drugs might leave patients vulnerable to severe viral infections.
AERIFY-1 trial met the primary endpoint of a statistically significant reduction in moderate or severe exacerbations in former smokers rega ...
11h
Irish Star on MSNFlorida on alert for massive Saharan dust storm as images show huge cloud approachingA huge cloud of Saharan dust is expected to hit Florida over the weekend and stay there for several days, with the dust cloud ...
Eli Lilly and Company today announced that data from studies of orforglipron, insulin efsitora alfa, tirzepatide (Zepbound and Mounjaro), retatrutide, eloralintide and bimagrumab will be presented at ...
PARIS, France and TARRYTOWN, NY, USA I May 30, 2025 I The AERIFY-1 phase 3 study evaluating itepekimab in former smokers with inadequately controlled chronic ...
About itepekimab Itepekimab is a fully human monoclonal antibody that binds to and inhibits interleukin-33 (IL33), an initiator and amplifier of broad inflammation in COPD. IL33 is thought to be ...
Itepekimab, developed by Sanofi and Regeneron, met its primary endpoint in the AERIFY-1 phase 3 study for COPD, showing a 27% reduction in modera ...
("Checkpoint"), an immunotherapy and targeted oncology company. As part of the acquisition, Sun Pharma acquires UNLOXCYT™, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results